Skip to main content
. 2022 Feb 28;14(3):547. doi: 10.3390/pharmaceutics14030547

Figure 5.

Figure 5

(A) Effect of rosinidin on TC against that of STZ-induced diabetic rats (n = 6). Values are expressed as mean ± SEM. # p < 0.05, normal control vs. diabetic control; *** p < 0.001, diabetic control vs. rosinidin-10, rosinidin-20. (B) Effect of rosinidin on TG against that of STZ-induced diabetic rats (n = 6). Values are expressed as mean ± SEM. # p < 0.05, normal control vs. diabetic control; *** p < 0.001, diabetic control vs. rosinidin-10, rosinidin-20. (C) Effect of rosinidin on LDL-C against that of STZ-induced diabetic rats (n = 6). Values are expressed as mean ± SEM. # p < 0.05, normal control vs. diabetic control; *** p < 0.001, diabetic control vs. rosinidin-10, rosinidin-20. (D) Effect of rosinidin on HDL-C against that of STZ-induced diabetic rats (n = 6). Values are expressed as mean ± SEM. # p < 0.05, normal control vs. diabetic control; *** p < 0.001, diabetic control vs. rosinidin-10, rosinidin-20.